The Aurigene expertise
Aurigene Pharmaceutical Services offers an extensive array of discovery and development services for New Biological Entities (NBEs) through a state-of-the-art facility located in Hyderabad, India. Our large molecule discovery services are driven by the expertise of a talented team of scientists who are highly experienced in developing and delivering various advanced therapeutic modalities, including monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, protein therapeutics, mRNA, and CAR-T. We develop and adopt innovative technology platforms for faster, reliable and cost-effective solutions to complex problems throughout the biologics value chain. We also specialize in forward integrating large molecule discovery with clinical manufacturing and beyond.
Our Large Molecule Discovery services include
in-vitro Biology
and Screening
Our in vitro biology and screening division offers a wide spectrum of biochemical and cell-based assays to profile small and large molecule entities.
Molecular Biology
Services
Offering a vast range of services in the areas of recombinant DNA technology, antibody gene sequencing, mutagenesis, library generation, plasmid DNA preparation, microbial genome engineering, gene expression analysis and IVT mRNA synthesis.
mRNA Synthesis
Services
We have industry-leading expertise in high-quality, customized and scalable mRNA synthesis by in vitro transcription.
Zebrafish
Research Model
We have world-class expertise in conducting Zebrafish research (Danio rerio) models for drug discovery studies and screening of chemical compounds
Antibody Discovery
Services
All our antibody discovery programmes are designed with the therapeutic endpoint in mind, while the technology platform is selected accordingly. Our team has extensive experience in handling several technology platforms, such as humanized rodents, B-cell cloning, hybridoma, and display libraries.
Antibody Drug
Conjugate Services
Our talented ADC team is well experienced in a wide range of ADC technologies and is capable of adopting new technologies to support our clients' needs
Protein
Sciences
Offering a comprehensive suite of services to support stages from sequence optimization to final product generation (Gene to Protein)
Protein Crystallography
and Structural Biology
Offering a one-stop solution for determining 3D structure of proteins, protein-protein complexes, protein-small molecule complexes, and antibody-antigen complexes at high resolution through world-class protein crystallography services
Cell Line Engineering
and Development
Cell engineering services at Aurigene cater to both tool/reagent and biological product development requirements. We have strong expertise in generating recombinant/stable cell lines for complex and wide protein class targets.
Why Aurigene Services?
18 years
of expertise
Experience gained
from 100+ discovery
programmes
World-class
infrastructure
Track record
of delivering
8+ IND candidates
Flexible working
models
Quick
turnaround
time
Capabilities to
apply multiple
modalities
Seamless integration
capabilities with
Biology as well as
CDMO services
Integrated
project
management
Expertise in
various therapeutic
modalities
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market